According to the World Health Organization, cardiovascular disease (CVD) is the leading cause of death and disability in the world today. With more than 17.5 million deaths annually from CVD, finding effective treatment options is critical. Northwestern University Feinberg School of Medicine scientists are hard at work to find innovative new therapies to treat and prevent CVD.
The absence of obesity, diabetes and hypertension in middle age was associated with significantly fewer years lived with heart failure, according to a Northwestern Medicine study.
Coronary artery calcium — a sign of atherosclerosis — was found in more than one-third of women previously considered to be low-risk for heart disease, according to a Northwestern Medicine study.
In the first of its kind study, Northwestern Medicine scientists looked at the impact of this genetic condition on the risk of developing heart disease.
Burning kerosene and diesel fuel indoors for lighting, cooking and heating may increase the chance of developing fatal heart disease, according to recent research.
A minimally invasive procedure to repair aortic stenosis may be preferable to open-heart surgery when treating patients at intermediate risk of surgical mortality, according to recent research.
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
In a new study, patients treated with one-fourth of the dose of beta-blockers tested in large clinical trials had a 20 to 25 percent increase in survival, indicating that dosing likely needs to be personalized for patients to get the best benefit.
Northwestern Medicine scientists used "big data" tools to classify for the first time three distinct categories of a common heart failure syndrome. The findings may be used to better predict how diverse patients will respond to treatments.